alendronate has been researched along with Acute Liver Injury, Drug-Induced in 8 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts." | 1.37 | FDA-approved drug labeling for the study of drug-induced liver injury. ( Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011) |
| " Hepatotoxicity due to alendronate therapy is a rare but possible adverse effect." | 1.34 | Hepatotoxicity induced by alendronate therapy. ( Atalar, H; Turkay, C; Yanik, B, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M | 2 |
| Vijay, V | 1 |
| Shi, Q | 2 |
| Liu, Z | 2 |
| Fang, H | 2 |
| Tong, W | 3 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Suzuki, A | 1 |
| Thakkar, S | 1 |
| Yu, K | 1 |
| Hu, C | 1 |
| Yanik, B | 1 |
| Turkay, C | 1 |
| Atalar, H | 1 |
| Lieverse, RJ | 1 |
| Halabe, A | 1 |
| Lifschitz, BM | 1 |
| Azuri, J | 1 |
| de La Serna Higuera, C | 1 |
| Pérez Villoria, A | 1 |
| Rodríguez Gómez, S | 1 |
| Martínez Moreno, J | 1 |
| Betancourt González, A | 1 |
| Martín Arribas, M | 1 |
| Carrère, C | 1 |
| Duval, JL | 1 |
| Godard, B | 1 |
| De Jaureguiberry, JP | 1 |
| Ciribilli, JM | 1 |
2 reviews available for alendronate and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Pr | 2016 |
[Alendronate-induced hepatocellular lesion].
Topics: Aged; Alendronate; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Function Tests; Ost | 2001 |
6 other studies available for alendronate and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Des | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Hepatotoxicity induced by alendronate therapy.
Topics: Alendronate; Bone Density Conservation Agents; Chemical and Drug Induced Liver Injury; Female; Human | 2007 |
Hepatitis after alendronate.
Topics: Aged; Alendronate; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Follow-U | 1998 |
Liver damage due to alendronate.
Topics: Aged; Alendronate; Chemical and Drug Induced Liver Injury; Female; Humans; Liver; Liver Function Tes | 2000 |
[Severe acute hepatitis induced by alendronate].
Topics: Aged; Alendronate; Bone Density; Chemical and Drug Induced Liver Injury; Female; Humans; Osteoporosi | 2002 |